122 results
424B5
ADIL
Adial Pharmaceuticals Inc
18 Apr 24
Prospectus supplement for primary offering
5:31pm
and the satisfaction of any liquidation preference granted to the holders of any then-outstanding shares of preferred stock. Holders of shares of our … to or changes in the provisions relating to satisfaction and discharge of the indenture;
additions to or changes in the provisions relating to the modification
8-K
ADIL
Adial Pharmaceuticals Inc
18 Apr 24
Entry into a Material Definitive Agreement
5:27pm
Stock pursuant thereto, obligations to sell shares under the ATM Agreement are subject to satisfaction of certain conditions, including
8-K
EX-5.1
ADIL
Adial Pharmaceuticals Inc
18 Apr 24
Entry into a Material Definitive Agreement
5:27pm
have examined originals or copies, certified or otherwise identified to our satisfaction, of (i) the Registration Statement, (ii) the Prospectus, (iii
8-K
EX-1.1
ADIL
Adial Pharmaceuticals Inc
18 Apr 24
Entry into a Material Definitive Agreement
5:27pm
of its obligations hereunder and to the continuing satisfaction of the additional conditions specified in Section 6 of this Agreement.
(ix
8-K
EX-4.1
iuoa1
6 Mar 24
Adial Pharmaceuticals Announces Exercise of Warrants for $3.5 Million Gross Proceeds
4:21pm
8-K
EX-99.1
8wyqegsmqqv9m 5kg6v
6 Mar 24
Adial Pharmaceuticals Announces Exercise of Warrants for $3.5 Million Gross Proceeds
4:21pm
8-K
EX-4.2
epst0e4r s5mpwk
6 Mar 24
Adial Pharmaceuticals Announces Exercise of Warrants for $3.5 Million Gross Proceeds
4:21pm
8-K
EX-10.1
grycgxg3
6 Mar 24
Adial Pharmaceuticals Announces Exercise of Warrants for $3.5 Million Gross Proceeds
4:21pm
424B5
fa4uzj7xetnt
25 Jan 24
Prospectus supplement for primary offering
4:30pm
8-K
EX-99.1
0jry1
24 Oct 23
Adial Pharmaceuticals Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
4:48pm
8-K
EX-4.1
brci21d q5x9
24 Oct 23
Adial Pharmaceuticals Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
4:48pm
8-K
EX-4.2
j09nradr2k87 bv
24 Oct 23
Adial Pharmaceuticals Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
4:48pm